SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-027928
Filing Date
2022-05-09
Accepted
2022-05-09 18:30:12
Documents
2
Period of Report
2022-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1501
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3708
  Complete submission text file 0001209191-22-027928.txt   6531
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Issuer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEXIMMUNE 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address
Gandhi Leena (Reporting) CIK: 0001927002 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40045 | Film No.: 22906608